Structure of human G protein-coupled receptor kinase 2 in complex with the kinase inhibitor balanol.
G protein-coupled receptor kinase 2 (GRK2) is a pharmaceutical target for the treatment of cardiovascular diseases such as congestive heart failure, myocardial infarction, and hypertension. To better understand how nanomolar inhibition and selectivity for GRK2 might be achieved, we have determined crystal structures of human GRK2 in complex with Gbetagamma in the presence and absence of the AGC kinase inhibitor balanol. The selectivity of balanol among human GRKs is assessed.
Tesmer
John J G
JJ
Life Sciences Institute, University of Michigan, Ann Arbor, Michigan 48109-2216, USA. johntesmer@umich.edu
Tesmer
Valerie M
VM
Lodowski
David T
DT
Steinhagen
Henning
H
Huber
Jochen
J
D001381:Azepines / Q000737:chemistry*; D018360:Crystallography, X-Ray; D017868:Cyclic AMP-Dependent Protein Kinases / Q000037:antagonists & inhibitors*; D054769:G-Protein-Coupled Receptor Kinase 2 / Q000037:antagonists & inhibitors / Q000737:chemistry*; D044387:GTP-Binding Protein beta Subunits / Q000737:chemistry*; D044388:GTP-Binding Protein gamma Subunits / Q000737:chemistry*; D006801:Humans; D062385:Hydroxybenzoates / Q000737:chemistry*; D008958:Models, Molecular; D010766:Phosphorylation; D011485:Protein Binding; D011487:Protein Conformation; D014404:Tubulin / Q000737:chemistry
D001381:Azepines; D044387:GTP-Binding Protein beta Subunits; D044388:GTP-Binding Protein gamma Subunits; D062385:Hydroxybenzoates; D014404:Tubulin; C015405:ophiocordin; D017868:Cyclic AMP-Dependent Protein Kinases; C496567:GRK2 protein, human; D054769:G-Protein-Coupled Receptor Kinase 2